MBCGX
Price
$14.15
Change
+$0.11 (+0.78%)
Updated
Aug 25 closing price
Net Assets
1.86B
RGAGX
Price
$88.38
Change
+$0.62 (+0.71%)
Updated
Aug 25 closing price
Net Assets
342.42B
Interact to see
Advertisement

MBCGX vs RGAGX

MBCGX vs RGAGX Comparison Chart in %
View a ticker or compare two or three
VS
MBCGX vs. RGAGX commentary
Aug 26, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MBCGX is a Buy and RGAGX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGAGX has more cash in the bank: 342B vs. MBCGX (1.86B). RGAGX pays higher dividends than MBCGX: RGAGX (0.52) vs MBCGX (0.00). MBCGX was incepted earlier than RGAGX: MBCGX (25 years) vs RGAGX (17 years). MBCGX (1.16) is less costly to investors than RGAGX (0.29). RGAGX is a more actively managed with annual turnover of: 32.00 vs. MBCGX (14.00). RGAGX has a lower initial minimum investment than MBCGX: RGAGX (250) vs MBCGX (1000). RGAGX annual gain was more profitable for investors over the last year : 4.45 vs. MBCGX (-34.18). RGAGX return over 5 years is better than : 17.17 vs. MBCGX (-56.49).
MBCGXRGAGXMBCGX / RGAGX
Total Expense Ratio1.160.29400%
Annual Report Gross Expense Ratio1.160.29400%
Fund Existence25 years17 years-
Gain YTD0.1439.6931%
Front Load6%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.86B342B1%
Annual Yield % from dividends0.000.52-
Returns for 1 year-34.184.45-769%
Returns for 3 years-27.1849.00-55%
Returns for 5 years-56.4917.17-329%
Returns for 10 years-9.11107.30-8%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ELC19.880.11
+0.56%
Entergy Louisiana LLC
IJUN32.120.17
+0.52%
Innovator Intl Dev Pwr Bffr ETF - Jun
LRGC86.410.20
+0.23%
AB US Large Cap Strategic Equities ETF
OCTH24.190.01
+0.02%
Innovator Premium Income 20 Bar ETF Oct
BTAL12.00-0.20
-1.64%
AGF U.S. Market Neutral Anti-Beta